<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[agreement and patent litigation Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/agreement+and+patent+litigation.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to agreement and patent litigation]]></description>
	<s:counts start="0" returned="5" found="5" />
	<language>en-us</language>
	<item>
		<title><![CDATA[ev3 Inc. Announces Agreements in Principle to Settle Patent Litigation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_31/ai_n27427620]]></link>
		<description><![CDATA[PLYMOUTH, Minn. -- ev3 Inc. (NASDAQ:EVVV), today announced that the company and its subsidiaries reached agreements in principle to resolve patent infringement and other litigation with The Regents of the University of California and Boston Scientific Corporation. Products involved in the litigation include embolic protection devices and certain detachable embolic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 31 Oct 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[litigation]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/university+of+california.html"><![CDATA[University of California]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[American Medical Systems Signs Cross-Licensing Agreement with Caldera Medical; Patent Litigation Suit Dismissed Under Separate Agreement]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_July_5/ai_n26916671]]></link>
		<description><![CDATA[MINNEAPOLIS -- American Medical Systems Holdings, Inc. (NASDAQ:AMMD) and Caldera Medical, Inc. today announced that they have entered into a settlement and cross-license agreement. AMS filed suit against Caldera in November 2005 claiming that Caldera infringed on certain patents related to treating stress urinary incontinence. The companies have entered into...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 05 Jul 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/caldera+systems+inc..html"><![CDATA[Caldera Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Teva Announces Agreement with Cephalon Regarding Settlement of PROVIGIL® Patent Litigation; Parties Also Agree to Business Arrangements Related to Modafinil]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_9/ai_n15927346]]></link>
		<description><![CDATA[JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Teva Pharmaceuticals USA, Inc. announced today that they have entered into an agreement with Cephalon, Inc. (Nasdaq: CEPH) to settle their pending patent infringement disputes in the United States and the United Kingdom related to PROVIGILR modafinil Tablets (C-IV).]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 09 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/cephalon+inc..html"><![CDATA[Cephalon Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CEPH</category>
		<category domain="tickers">CEPH</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals Finalizes Agreement for the Settlement of Mircette® Litigation; Transaction Terminates Patent Litigation and Results in $13.75 Million Payment To Savient]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_2/ai_n15892259]]></link>
		<description><![CDATA[EAST BRUNSWICK, N.J. -- Savient Pharmaceuticals, Inc. ("Savient") (NASDAQ: SVNTE), an emerging specialty pharmaceutical company engaged in developing, manufacturing and marketing pharmaceutical products that address unmet medical needs in niche and broader markets, announced today that it has concluded with Barr Pharmaceuticals, Inc. ("Barr") (NYSE: BRL), Organon USA Inc. and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/barr+pharmaceuticals+inc..html"><![CDATA[Barr Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[litigation]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/payment.html"><![CDATA[payment]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BRL</category>
		<category domain="tickers">BRL</category>
	</item>
	<item>
		<title><![CDATA[Intersil and Proxim Reach Settlement on Patent Litigation; Companies Sign Patent Cross-License and Product Supply Agreements]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2003_March_17/ai_98867685]]></link>
		<description><![CDATA[Business Editors/High-Tech Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Mar 2003 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/intersil.html"><![CDATA[Intersil]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISIL</category>
		<category domain="tickers">ISIL</category>
	</item>
</channel>
</rss>
